MX2019012765A - Proceso para la fabricacion de la forma alfa de vortioxetina hbr. - Google Patents

Proceso para la fabricacion de la forma alfa de vortioxetina hbr.

Info

Publication number
MX2019012765A
MX2019012765A MX2019012765A MX2019012765A MX2019012765A MX 2019012765 A MX2019012765 A MX 2019012765A MX 2019012765 A MX2019012765 A MX 2019012765A MX 2019012765 A MX2019012765 A MX 2019012765A MX 2019012765 A MX2019012765 A MX 2019012765A
Authority
MX
Mexico
Prior art keywords
manufacture
alpha
vortioxetine hbr
vortioxetine
hbr
Prior art date
Application number
MX2019012765A
Other languages
English (en)
Inventor
Petersen Hans
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62111030&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2019012765(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MX2019012765A publication Critical patent/MX2019012765A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se proporciona un proceso para la fabricación de la forma a de vortioxetina HBr.
MX2019012765A 2017-04-25 2018-04-20 Proceso para la fabricacion de la forma alfa de vortioxetina hbr. MX2019012765A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201700264 2017-04-25
PCT/EP2018/060192 WO2018197360A1 (en) 2017-04-25 2018-04-20 Process for the manufacture of vortioxetine hbr alpha-form

Publications (1)

Publication Number Publication Date
MX2019012765A true MX2019012765A (es) 2019-12-05

Family

ID=62111030

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019012765A MX2019012765A (es) 2017-04-25 2018-04-20 Proceso para la fabricacion de la forma alfa de vortioxetina hbr.

Country Status (26)

Country Link
US (1) US11124491B2 (es)
EP (1) EP3615518B1 (es)
JP (1) JP7121751B2 (es)
KR (1) KR102551433B1 (es)
CN (1) CN110520415A (es)
AU (1) AU2018258947C1 (es)
BR (1) BR112018076411A2 (es)
CA (1) CA3059515A1 (es)
CL (1) CL2019003024A1 (es)
CO (1) CO2019011592A2 (es)
CY (1) CY1124974T1 (es)
DK (1) DK3615518T3 (es)
ES (1) ES2905962T3 (es)
HR (1) HRP20220108T1 (es)
HU (1) HUE057993T2 (es)
IL (1) IL270052B2 (es)
LT (1) LT3615518T (es)
MA (1) MA49056A (es)
MX (1) MX2019012765A (es)
PL (1) PL3615518T3 (es)
PT (1) PT3615518T (es)
RS (1) RS62823B1 (es)
SG (1) SG11201909678PA (es)
SI (1) SI3615518T1 (es)
WO (1) WO2018197360A1 (es)
ZA (1) ZA201906829B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210087155A1 (en) * 2018-02-06 2021-03-25 Piramal Enterprises Limited An improved process for the preparation of vortioxetine and salts thereof
CN112125868B (zh) * 2020-09-25 2021-08-03 中山万远新药研发有限公司 一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
CN102614179B (zh) * 2006-06-16 2015-11-25 H.隆德贝克有限公司 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2，4-二甲基苯基硫烷基)-苯基]哌嗪
TW200848411A (en) * 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
WO2014044721A1 (en) 2012-09-19 2014-03-27 Sandoz Ag Novel crystalline form of vortioxetine hydrobromide
EA029060B1 (ru) * 2014-01-31 2018-02-28 Эгиш Дьёдьсердьяр Зрт. Способ получения солей вортиоксетина
US9687484B2 (en) 2014-07-18 2017-06-27 Dipharma Francis S.R.L. Crystalline forms of an antidepressant compound
CN105367515B (zh) 2015-05-08 2017-10-27 北京北陆药业股份有限公司 一种氢溴酸沃替西汀α晶型的制备方法
CN104910099B (zh) 2015-05-22 2017-03-08 扬子江药业集团有限公司 一种氢溴酸沃替西汀晶体的制备方法
CN106316986B (zh) 2015-07-03 2019-02-05 成都弘达药业有限公司 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪氢溴酸盐α型晶体的制备方法

Also Published As

Publication number Publication date
RU2019133770A3 (es) 2021-08-27
ZA201906829B (en) 2022-03-30
US11124491B2 (en) 2021-09-21
RS62823B1 (sr) 2022-02-28
PL3615518T3 (pl) 2022-03-07
JP2020517674A (ja) 2020-06-18
PT3615518T (pt) 2022-02-14
EP3615518A1 (en) 2020-03-04
SG11201909678PA (en) 2019-11-28
CY1124974T1 (el) 2023-01-05
CL2019003024A1 (es) 2020-02-21
LT3615518T (lt) 2022-03-10
IL270052B1 (en) 2023-08-01
AU2018258947C1 (en) 2021-08-26
IL270052B2 (en) 2023-12-01
BR112018076411A2 (pt) 2019-04-09
KR20190141155A (ko) 2019-12-23
CN110520415A (zh) 2019-11-29
CO2019011592A2 (es) 2019-10-31
CA3059515A1 (en) 2018-11-01
AU2018258947B2 (en) 2021-02-25
DK3615518T3 (da) 2022-02-07
JP7121751B2 (ja) 2022-08-18
AU2018258947A1 (en) 2019-10-31
HRP20220108T1 (hr) 2022-04-15
HUE057993T2 (hu) 2022-06-28
EP3615518B1 (en) 2021-12-15
ES2905962T3 (es) 2022-04-12
IL270052A (es) 2019-12-31
KR102551433B1 (ko) 2023-07-04
RU2019133770A (ru) 2021-05-25
WO2018197360A1 (en) 2018-11-01
MA49056A (fr) 2020-03-04
SI3615518T1 (sl) 2022-02-28
US20200165217A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
EP4275747A3 (en) Therapeutic applications of cpf1-based genome editing
GR20140100479A (el) Συνθεση λιραγλουτιδης
EP3630738A4 (en) METHOD OF MANUFACTURING OZANIMOD
MX2017008280A (es) Proceso para elaborar cenicriviroc y analogos relacionados.
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
CY1124974T1 (el) Διαδικασια για την παρασκευη βορτιοξετινης hbr αλφα-μορφης
MX2020004093A (es) Puzolana de vidrio activada.
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
MX2023009431A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
MX2019002017A (es) Derivados de sofosbuvir para el tratamiento de la hepatitis c.
EP3847675C0 (en) PROCESS FOR THE PRODUCTION OF GALLIUM RADIONUCLIDES
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
MY174200A (en) Process for reducing the chlorine content of organotetraphosphites
MX2018011529A (es) Procesos para la preparacion de acidos heteroaril carboxilicos.
MY180413A (en) Process for the decomposition of lignocellulose-containing biomass-material
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2019006956A (es) Proceso para la fabricacion de derivados de diazepina.
WO2018198101A3 (en) Processes for the preparation of crystalline form of eluxadoline
PL3415011T3 (pl) Procedura wytwarzania półskorupek waflowych
EP3645487A4 (en) ETHYLENE GLYCOL MANUFACTURING PROCESS
MX2017007510A (es) Un proceso para la fabricacion de idalopirdina.
MY194660A (en) Alkoxycarbonylation of trivinylcyclohexane
GB201717809D0 (en) Process for the production of cobimetinib
MX2018009943A (es) Proceso para la fabricacion de derivados de 3-piperazin-1-il-propi lamina.